Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)
Clinical trial NCT06225336 · TERMINATED
Trial details
- NCT number
- NCT06225336
- Sponsor
- Auregen Biotherapeutics, SA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-04
- Primary completion
- 2025-09-10
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.